Marc Taraban

Dr. Marc Taraban is an Associate Research Professor in the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy. His research focuses on the application of advanced biophysical techniques to study biopharmaceuticals, biomacromolecules, and novel drug delivery systems. He specializes in dynamic NMR, SAXS, and other structural methods to analyze conformational dynamics and material properties.

Dr. Taraban's research interests center on noninvasive analytical technologies for biopharmaceuticals, particularly using water proton NMR to probe protein aggregation, hydrogel mechanics, and vaccine formulations. His work bridges pharmaceutical sciences, polymer physics, and structural biology, with a strong emphasis on translational applications such as injectable mechanosensors and controlled drug release matrices for tissue repair.

The trend in his recent publications reveals a consistent focus on water relaxation rate as a sensitive, noninvasive probe for characterizing biopharmaceuticals and soft materials. His studies span from fundamental biophysical investigations to process analytical technology in biomanufacturing, demonstrating a trajectory toward real-time, quality-control applications in pharmaceutical development.

Scientific Contributions:

• Holds a patent for noninvasive analytical technologies
• Pioneered CIDNP studies of enzymatic reactions and magnetic field effects
• Developed force-sensitive nano-networks (FSNNs) from biopolymers
• Advanced in-line NMR for continuous biomanufacturing

Dr. Taraban has secured research funding and collaborates extensively with Dr. Bruce Yu and Dr. K.T. Briggs at the University of Maryland. His work involves interdisciplinary grants focused on biopharmaceutical safety, quality control, and novel biomaterials. While no formal students are listed, his publications suggest mentorship roles in collaborative research projects.

He is actively involved in a research lab focused on biophysical characterization of pharmaceutical systems, where his team develops and applies NMR and scattering techniques to understand molecular assembly, aggregation, and material behavior in therapeutic contexts.